| A comprehensive review and meta-analysis of risk factors for statin-induced myopathy KA Nguyen, L Li, D Lu, A Yazdanparast, L Wang, RP Kreutz, EC Whipple, ... European journal of clinical pharmacology 74, 1099-1109, 2018 | 81 | 2018 |
| Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications D Spakowicz, R Hoyd, M Husain, JS Bassett, L Wang, G Tinoco, S Patel, ... BMC Cancer, 2020 | 51 | 2020 |
| Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort J Li, Q Zhang, F Chen, X Meng, W Liu, D Chen, J Yan, S Kim, L Wang, ... Neurobiology of aging 57, 247. e1-247. e8, 2017 | 33 | 2017 |
| Genetic interactions explain variance in cingulate amyloid burden: an AV-45 PET genome-wide association and interaction study in the ADNI cohort J Li, Q Zhang, F Chen, J Yan, S Kim, L Wang, W Feng, AJ Saykin, H Liang, ... BioMed research international 2015, 2015 | 31 | 2015 |
| Translational high‐dimensional drug interaction discovery and validation using health record databases and pharmacokinetics models CW Chiang, P Zhang, X Wang, L Wang, S Zhang, X Ning, L Shen, ... Clinical Pharmacology & Therapeutics 103 (2), 287-295, 2018 | 27 | 2018 |
| Propensity score‐adjusted three‐component mixture model for drug‐drug interaction data mining in FDA Adverse Event Reporting System X Wang, L Li, L Wang, W Feng, P Zhang Statistics in Medicine 39 (7), 996-1010, 2020 | 21 | 2020 |
| Translational biomedical informatics and pharmacometrics approaches in the drug interactions research P Zhang, HY Wu, CW Chiang, L Wang, S Binkheder, X Wang, D Zeng, ... CPT: pharmacometrics & systems pharmacology 7 (2), 90-102, 2018 | 19 | 2018 |
| A Mixture Dose–Response Model for Identifying High‐Dimensional Drug Interaction Effects on Myopathy Using Electronic Medical Record Databases P Zhang, L Du, L Wang, M Liu, L Cheng, CW Chiang, HY Wu, SK Quinney, ... CPT: pharmacometrics & systems pharmacology 4 (8), 474-480, 2015 | 18 | 2015 |
| A modified brain MR image segmentation and bias field estimation model based on local and global information W Cong, J Song, K Luan, H Liang, L Wang, X Ma, J Li Computational and mathematical methods in medicine 2016, 2016 | 16 | 2016 |
| Mixture drug‐count response model for the high‐dimensional drug combinatory effect on myopathy X Wang, P Zhang, CW Chiang, H Wu, L Shen, X Ning, D Zeng, L Wang, ... Statistics in medicine 37 (4), 673-686, 2018 | 12 | 2018 |
| How to choose in vitro systems to predict in vivo drug clearance: a system pharmacology perspective L Wang, CW Chiang, H Liang, H Wu, W Feng, SK Quinney, J Li, L Li BioMed Research International 2015, 2015 | 12 | 2015 |
| Translational knowledge discovery between drug interactions and pharmacogenetics HY Wu, A Shendre, S Zhang, P Zhang, L Wang, D Zeruesenay, LM Rocha, ... Clinical Pharmacology & Therapeutics 107 (4), 886-902, 2020 | 11 | 2020 |
| A fuzzy c-means clustering scheme incorporating non-local spatial constraint for brain magnetic resonance image segmentation W Cong, J Song, L Wang, H Liang, J Li Journal of Medical Imaging and Health Informatics 5 (8), 1821-1825, 2015 | 10 | 2015 |
| MatPred: computational identification of mature micrornas within novel pre-MicroRNAs J Li, Y Wang, L Wang, W Feng, K Luan, X Dai, C Xu, X Meng, Q Zhang, ... BioMed research international 2015, 2015 | 9 | 2015 |
| The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics SK Quinney, RR Bies, SJ Grannis, CW Bartlett, E Mendonca, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (5 …, 2023 | 8 | 2023 |
| The cancer drug fraction of metabolism database L Hua, CW Chiang, W Cong, J Li, X Wang, L Cheng, W Feng, SK Quinney, ... CPT: pharmacometrics & systems pharmacology 8 (7), 511-519, 2019 | 8 | 2019 |
| Three‐component mixture model‐based adverse drug event signal detection for the adverse event reporting system P Zhang, M Li, CW Chiang, L Wang, Y Xiang, L Cheng, W Feng, ... CPT: Pharmacometrics & Systems Pharmacology 7 (8), 499-506, 2018 | 8 | 2018 |
| Integrative network analysis of rifampin-regulated miRNAs and their functions in human hepatocytes J Li, Y Wang, L Wang, H Liang, W Feng, X Meng, W Cong, Y Liu Bio-Medical Materials and Engineering 26 (s1), S1985-S1991, 2015 | 7 | 2015 |
| Identification of rifampin-regulated functional modules and related microRNAs in human hepatocytes based on the protein interaction network J Li, Y Wang, L Wang, X Dai, W Cong, W Feng, C Xu, Y Deng, Y Wang, ... BMC genomics 17, 259-270, 2016 | 6 | 2016 |
| Identifying clinically relevant drug–drug interactions with methadone and buprenorphine: a translational approach to signal detection TA Miano, L Wang, CE Leonard, CM Brensinger, EK Acton, GK Dawwas, ... Clinical Pharmacology & Therapeutics 112 (5), 1120-1129, 2022 | 5 | 2022 |
